Archives: Agenda

• Emerging themes and technology advancements in biopharma
• Leveraging data to predict the outlook for 2025 clinical trials
• Trends, key players, opportunities, and threats in clinical trial outsourcing
• Latest biopharma investor activity: venturing financing, IPOs, and grants

During the roundtable discussion session, the conference hall will be divided into four ‘zones’. Delegates can choose which zone they would like to join. Each zone will focus on a different challenge within clinical operations.

ROUNDTABLE 1: Developing a successful Diversity Action Plan for your clinical trial
ROUNDTABLE 2: Creating an AI strategy to support clinical research
ROUNDTABLE 3: Key considerations when selecting a CRO
ROUNDTABLE 4: Working with advocacy groups to keep the patient voice at the heart of your trial

• Technology and innovation for addressing health literacy and how information is presented to patients
• Integrating health literacy principles into all phases of clinical research
• How low health literacy can

• Defining the full lifecycle of clinical and regulatory documents
• Identifying practical actions authors can take to facilitate compliance with electronic regulatory submission requirements
• Describing how technology tools are used to ensure efficient workflows and regulatory compliance

• Top tips for working with and supporting naïve physicians in order to ensure their success
• The importance of new study sites as a way of meeting FDA diversity requirements
• Lessons learned for the future: what should you consider when working with naïve doctors?

Carrie Lewis, Executive Director, Clinical Program
Optimization, Endo
Suzy Montanye, Site Relationship Manager, Endo

• Opportunities for incorporating AI into clinical research: where should the industry be focusing?
• Why has pharma been relatively slow to utilize AI in clinical research?
• Understanding limitations of GenAI: what do you need to be wary of?
• Real case studies on AI in the clinical trial industry: where has there been progress and success?
• What does the future hold for AI in clinical trials?

MODERATOR:
Judyth Zahora, Senior Director, Clinical QA and Process Improvement, Zentalis Pharmaceuticals

• Discover how integrating health equity & SDoH data improves patient representation and accessibility in clinical trials
• Learn how H1 supports sponsors in designing inclusive, patient-centric trials to meet diversity action plan requirements and feasibility benchmarks
• Explore real-world applications of inclusive research strategies that have successfully expanded patient diversity and engagement

• What sites really want and need, and why they don’t understand sponsors
• What sponsors really want and need, and why they don’t understand sites
• Areas of common ground
• How sites and sponsors can reconcile and work together to find success